Moderna https://www.reuters.com/markets/companies/MRNA.O” target=”_blank” rel=”noopener”>(MRNA.O) on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus…
Read More
About The Author
